KAYLEY HURT: Open Payments
NPI 1427690635 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,300 in 191 payments from 20 companies in 2025. Trend: 2023 $2,203 · 2024 $3,226 · 2025 $4,300
Food & beverage: $4,166Education: $134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 38 | $818 |
| GlaxoSmithKline, LLC. | 31 | $475 |
| Regeneron Healthcare Solutions, Inc. | 18 | $424 |
| GENZYME CORPORATION | 14 | $414 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $387 |
| Grifols USA, LLC | 10 | $310 |
| Amgen Inc. | 13 | $251 |
| Viatris Specialty LLC | 11 | $212 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $180 |
| JAZZ PHARMACEUTICALS INC. | 7 | $151 |
Products named: DUPIXENT, GLASSIA, TEZSPIRE, Prolastin-C Liquid, AIRSUPRA, NUCALA, YUPELRI, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
